Stockscreener 앱 받기
25.50
3.41%
0.84
시간 외 거래:
25.50
전일 마감가:
$24.66
열려 있는:
$24.36
하루 거래량:
552.33K
Relative Volume:
1.13
시가총액:
$1.19B
수익:
$722.68M
순이익/손실:
$134.71M
주가수익비율:
9.5506
EPS:
2.67
순현금흐름:
$109.94M
1주 성능:
+4.00%
1개월 성능:
-4.32%
6개월 성능:
+4.47%
1년 성능:
-49.53%
1일 변동 폭
$24.24
$25.60
1주일 범위
$23.77
$25.60
52주 변동 폭
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.50 | 1.15B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 업그레이드 | Needham | Hold → Buy |
| 2025-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesInsider Selling & Real-Time Stock Movement Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025July 2025 Decliners & Target Return Focused Picks - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly dataShare Buyback & AI Powered Market Entry Strategies - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsProduct Launch & Fast Entry Momentum Alerts - newser.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Amphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
United States Anaphylaxis Treatment Market 2025: Industry - openPR.com
Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.18%
1.86%
자본화:
|
볼륨(24시간):